GW & Wade’s Invesco Pharmaceuticals ETF PJP Stock Holding History

GW & Wade’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$483K	Hold	6,341	–	–	0.02%	296
2023 Q3	$459K	Hold	6,341	–	–	0.02%	283
2023 Q2	$480K	Sell	6,341 -50	-0.8%	-$3.82K	0.02%	278
2023 Q1	$486K	Hold	6,391	–	–	0.02%	264
2022 Q4	$502K	Sell	6,391 -201	-3%	-$15.4K	0.02%	254
2022 Q3	$470K	Sell	6,592 -95	-1%	-$7.08K	0.02%	248
2022 Q2	$501K	Buy	6,687 +96	+1%	+$7.28K	0.02%	253
2022 Q1	$525K	Hold	6,591	–	–	0.02%	240
2021 Q4	$535K	Hold	6,591	–	–	0.02%	242
2021 Q3	$510K	Buy	6,591 +25	+0.4%	+$2.02K	0.02%	244
2021 Q2	$528K	Buy	6,566 +1,515	+30%	+$120K	0.03%	241
2021 Q1	$398K	Buy	5,051 +2,095	+71%	+$163K	0.02%	251
2020 Q4	$211K	Buy	+2,956	New	+$198K	0.01%	295

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

GW & Wade's PJP Position: Q4 2023 in Review

GW & Wade held its Invesco Pharmaceuticals ETF (PJP) position steady in Q4 2023 at 6,341 shares worth $483K. The position accounts for 0.02% of the portfolio, ranked #296.

GW & Wade first reported a position in PJP in Q4 2020 and has held it in 13 quarters since. The position peaked at $535K in Q4 2021. 86 funds tracked by Wall St. Rank hold PJP as of Q4 2023.

GW & Wade held 6,341 shares of Invesco Pharmaceuticals ETF worth $483K as of Q4 2023.
GW & Wade left its Invesco Pharmaceuticals ETF share count unchanged in Q4 2023.
Invesco Pharmaceuticals ETF made up 0.02% of GW & Wade's portfolio in Q4 2023, its #296 holding.
GW & Wade first reported a position in Invesco Pharmaceuticals ETF in Q4 2020 and has held it in 13 quarters since.
GW & Wade's Invesco Pharmaceuticals ETF position peaked at $535K in Q4 2021.
86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.